{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:03:26Z","timestamp":1772118206745,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00228-024-03641-5","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T13:02:46Z","timestamp":1707397366000},"page":"685-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"80","author":[{"given":"Rongda","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"issue":"10343","key":"3641_CR1","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/s0140-6736(22)00536-0","volume":"399","author":"A Kattamis","year":"2022","unstructured":"Kattamis A, Kwiatkowski JL, Aydinok Y (2022) Thalassaemia. Lancet 399(10343):2310\u20132324. https:\/\/doi.org\/10.1016\/s0140-6736(22)00536-0","journal-title":"Lancet"},{"issue":"8","key":"3641_CR2","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1097\/HS9.0000000000000732","volume":"6","author":"D Farmakis","year":"2022","unstructured":"Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A (2022) 2021 Thalassaemia international federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere 6(8):e732. https:\/\/doi.org\/10.1097\/HS9.0000000000000732","journal-title":"Hemasphere"},{"issue":"3","key":"3641_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4067\/s0716-97602012000300012","volume":"45","author":"F Barriga","year":"2012","unstructured":"Barriga F, Ram\u00edrez P, Wietstruck A, Rojas N (2012) Hematopoietic stem cell transplantation: clinical use and perspectives. Biol Res 45(3):307\u2013316. https:\/\/doi.org\/10.4067\/s0716-97602012000300012","journal-title":"Biol Res"},{"key":"3641_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100792","volume":"48","author":"N Martinez-Cibrian","year":"2021","unstructured":"Martinez-Cibrian N, Zeiser R, Perez-Simon JA (2021) Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions. Blood Rev 48:100792. https:\/\/doi.org\/10.1016\/j.blre.2020.100792","journal-title":"Blood Rev"},{"issue":"2 Suppl","key":"3641_CR5","doi-asserted-by":"publisher","first-page":"378S","DOI":"10.1016\/j.transproceed.2004.01.091","volume":"36","author":"BD Kahan","year":"2004","unstructured":"Kahan BD (2004) Therapeutic drug monitoring of cyclosporine: 20 years of progress. Transplant Proc 36(2 Suppl):378S-391S. https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.091","journal-title":"Transplant Proc"},{"issue":"11","key":"3641_CR6","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s11095-021-03114-9","volume":"38","author":"J Mao","year":"2021","unstructured":"Mao J, Qiu X, Qin W, Xu L, Zhang M, Zhong M (2021) Factors affecting time-varying clearance of cyclosporine in adult renal transplant recipients: a population pharmacokinetic perspective. Pharm Res 38(11):1873\u20131887. https:\/\/doi.org\/10.1007\/s11095-021-03114-9","journal-title":"Pharm Res"},{"issue":"4","key":"3641_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jcpt.13569","volume":"47","author":"J Ling","year":"2022","unstructured":"Ling J, Yang XP, Dong LL, Jiang Y, Zou SL, Hu N, Chen R (2022) Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance. J Clin Pharm Ther 47(4):483\u2013492. https:\/\/doi.org\/10.1111\/jcpt.13569","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"3641_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/maj.0000000000000337","volume":"348","author":"L Xue","year":"2014","unstructured":"Xue L, Zhang WW, Ding XL, Zhang JJ, Bao JA, Miao LY (2014) Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients. Am J Med Sci 348(6):448\u2013454. https:\/\/doi.org\/10.1097\/maj.0000000000000337","journal-title":"Am J Med Sci"},{"issue":"1","key":"3641_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11095-019-2740-2","volume":"37","author":"L Xue","year":"2019","unstructured":"Xue L, Zhang WJ, Tian JX, Liu LN, Yan HH, Zhang WW, Ding XL, Zhang JJ, Miao LY (2019) Multicenter-based population pharmacokinetic analysis of ciclosporin in hematopoietic stem cell transplantation patients. Pharm Res 37(1):15. https:\/\/doi.org\/10.1007\/s11095-019-2740-2","journal-title":"Pharm Res"},{"issue":"12","key":"3641_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41401-019-0277-x","volume":"40","author":"TF Li","year":"2019","unstructured":"Li TF, Hu L, Ma XL, Huang L, Liu XM, Luo XX, Feng WY, Wu CF (2019) Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation. Acta Pharmacol Sin 40(12):1603\u20131610. https:\/\/doi.org\/10.1038\/s41401-019-0277-x","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"3641_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.5414\/CP201815","volume":"51","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Sheng XY, Xu JY, Bi SS, Lu W, Cui YM (2013) Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients. Int J Clin Pharmacol Ther 51(7):568\u2013575. https:\/\/doi.org\/10.5414\/CP201815","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"3641_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13318-012-0087-8","volume":"37","author":"H Zhou","year":"2012","unstructured":"Zhou H, Gao Y, Cheng XL, Li ZD (2012) Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients. Eur J Drug Metab Pharmacokinet 37(4):271\u2013278. https:\/\/doi.org\/10.1007\/s13318-012-0087-8","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"3641_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2125.2008.03217.x","volume":"66","author":"AJ Willemze","year":"2008","unstructured":"Willemze AJ, Cremers SC, Schoemaker RC, Lankester AC, den Hartigh J, Burggraaf J, Vossen JM (2008) Ciclosporin kinetics in children after stem cell transplantation. Br J Clin Pharmacol 66(4):539\u2013545. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03217.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3641_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s1083-8791(03)00076-4","volume":"9","author":"PA Jacobson","year":"2003","unstructured":"Jacobson PA, Ng J, Green KG, Rogosheske J, Brundage R (2003) Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 9(5):304\u2013311. https:\/\/doi.org\/10.1016\/s1083-8791(03)00076-4","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"3641_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00228-006-0224-x","volume":"63","author":"N Somparn","year":"2007","unstructured":"Somparn N, Kukongviriyapan U, Tassaneeyakul W, Jetsrisuparb A, Kukongviriyapan V (2007) Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Eur J Clin Pharmacol 63(1):43\u201350. https:\/\/doi.org\/10.1007\/s00228-006-0224-x","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"3641_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/bmt.2009.316","volume":"45","author":"S Kimura","year":"2009","unstructured":"Kimura S, Oshima K, Okuda S, Sato K, Sato M, Terasako K, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Kanda Y (2009) Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 45(6):1088\u20131094. https:\/\/doi.org\/10.1038\/bmt.2009.316","journal-title":"Bone Marrow Transplant"},{"issue":"2 Suppl","key":"3641_CR17","doi-asserted-by":"publisher","first-page":"396s","DOI":"10.1016\/j.transproceed.2004.01.013","volume":"36","author":"A Jorga","year":"2004","unstructured":"Jorga A, Holt DW, Johnston A (2004) Therapeutic drug monitoring of cyclosporine. Transplant Proc 36(2 Suppl):396s\u2013403s. https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.013","journal-title":"Transplant Proc"},{"issue":"2","key":"3641_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5414\/CP203921","volume":"60","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, He H, Zang Y, Zhao L, Wang X (2022) Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: effects of weight and total cholesterol. Int J Clin Pharmacol Ther 60(2):87\u201396. https:\/\/doi.org\/10.5414\/CP203921","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3641_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ, Holford NH (2008) Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 48:303\u2013332. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094708","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"3641_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/pharmaceutics11060259","volume":"11","author":"HM Back","year":"2019","unstructured":"Back HM, Lee JB, Han N, Goo S, Jung E, Kim J, Song B, An SH, Kim JT, Rhie SJ, Ree YS, Chae JW, Kim J, Yun HY (2019) Application of size and maturation functions to population pharmacokinetic modeling of pediatric patients. Pharmaceutics 11(6):259. https:\/\/doi.org\/10.3390\/pharmaceutics11060259","journal-title":"Pharmaceutics"},{"issue":"6","key":"3641_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/j.1365-2125.2007.03003.x","volume":"64","author":"S Fanta","year":"2007","unstructured":"Fanta S, Jonsson S, Backman JT, Karlsson MO, Hoppu K (2007) Developmental pharmacokinetics of ciclosporin\u2013a population pharmacokinetic study in paediatric renal transplant candidates. Br J Clin Pharmacol 64(6):772\u2013784. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.03003.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3641_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/s0169-409x(03)00030-9","volume":"55","author":"J Alcorn","year":"2003","unstructured":"Alcorn J, McNamara PJ (2003) Pharmacokinetics in the newborn. Adv Drug Deliv Rev 55(5):667\u2013686. https:\/\/doi.org\/10.1016\/s0169-409x(03)00030-9","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3641_CR23","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"National Heart, Lung, and Blood Institute","year":"2011","unstructured":"National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(5):S213\u2013S256. https:\/\/doi.org\/10.1542\/peds.2009-2107C","journal-title":"Pediatrics"},{"issue":"1","key":"3641_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","volume":"19","author":"P Manikandan","year":"2018","unstructured":"Manikandan P, Nagini S (2018) Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets 19(1):38\u201354. https:\/\/doi.org\/10.2174\/1389450118666170125144557","journal-title":"Curr Drug Targets"},{"issue":"2","key":"3641_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1389200219666181003142036","volume":"20","author":"Y Akamine","year":"2019","unstructured":"Akamine Y, Yasui-Furukori N, Uno T (2019) Drug-drug interactions of P-gp substrates unrelated to CYP metabolism. Curr Drug Metab 20(2):124\u2013129. https:\/\/doi.org\/10.2174\/1389200219666181003142036","journal-title":"Curr Drug Metab"},{"issue":"1","key":"3641_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","volume":"30","author":"JE Nett","year":"2016","unstructured":"Nett JE, Andes DR (2016) Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin North Am 30(1):51\u201383. https:\/\/doi.org\/10.1016\/j.idc.2015.10.012","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"3641_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","volume":"45","author":"R Bellmann","year":"2017","unstructured":"Bellmann R, Smuszkiewicz P (2017) Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection 45(6):737\u2013779. https:\/\/doi.org\/10.1007\/s15010-017-1042-z","journal-title":"Infection"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03641-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T06:03:37Z","timestamp":1712556217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03641-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03641-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Ethics approval number:2023-E270-01) and carried out under the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the nature of a retrospective study, the acquisition of written informed consent to participate in the study and publication of the data from patients\u2019 parents was beyond feasibility. And the waiver of informed consent was granted by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"There is no identifying information on any patient in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}